NSE:ERIS News | QuoteStream

quartr

ERIS: Q1 FY27 saw robust revenue and profit growth, major acquisition, and interim dividend declaration

Consolidated Q1 FY27 revenue rose to ₹873.25 crore and net profit to ₹143.32 crore, with strong margins and improved year-over-year performance. Key developments include a major acquisition, interim dividend declaration, and the impact of new labour codes and tax changes.Original document: Eris Lif…

Quartr en_IN 29/7/2026, 04:34 pm GMT+8

StocksIN

ERIS

quartr

ERIS: Q1 FY27 saw 13% revenue and 14.5% PAT growth, led by DBF and GLP-1 market gains

Q1 FY27 delivered 13% revenue and 14.5% PAT growth year-over-year, with strong DBF segment momentum and leadership in GLP-1 and insulin market share. EBITDA margin compressed slightly, while priorities focus on therapy momentum, new launches, and capacity expansion.Original document: Eris Lifescien…

Quartr en_IN 29/7/2026, 03:59 pm GMT+8

StocksIN